Page 5 - Genentech News Today

Novartis Pharmaceuticals, Bayer, GlaxoSmithKline, and eight other major pharmaceutical firms have disclosed the compromise of their patients' information following a cyberattack against large U.S. pharmaceutical services provider Cencora, formerly known as AmericsourceBergen, in February, reports BleepingComputer.

Basel, 27 May 2024 - Roche announced today that James Sabry , Head of Roche Pharma Partnering, will be retiring after fourteen years with the company. James Sabry joined Genentech in 2010 as Head...

Basel, 27 May 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that James Sabry (1958), Head of Roche Pharma Partnering, will be retiring after fourteen years with the company. James Sabry

/PRNewswire/ -- Roche announced today that Hitachi High-Tech and Roche have extended their partnership, committing to at least 10 years of additional...

Renewed partnership combines best in class engineering capabilities with cutting edge science to accelerate the availability of new solutions for customers and patients worldwideUpcoming launches of the new cobas®

Roche announced that James Sabry , Head of Roche Pharma Partnering, will be retiring after fourteen years with the company. James Sabry joined Genentech in 2010 as Head of Genentech Partnering. In...

As the era of biologics and biosimilar litigations heats up in the United States, Europe's Unified Patent Court (UPC) is also taking center stage with the first two biosimilar disputes filed in March and April.

Vaccines for particular skin and lung cancer types have advanced to the last stage of clinical trials in recent months.

USA News Group News Commentary – As the 2024 American Society of Clinical Oncology (ASCO) annual meeting approaches, excitement builds over the latest in cancer treatment advancements, particularly in Antibody-Drug Conjugates (ADCs). From May 31 ...

Investegate announcements from Notice of Results